Created at	Source	Raw Value	Validated value
April 27, 2023, 4 a.m.	usa	Immunogenicity at Phase II Study;Immunogenicity at Phase II Study;Safety at Phase II Study;Safety at Phase II Study;Safety at Phase II Study	Immunogenicity at Phase II Study;Immunogenicity at Phase II Study;Safety at Phase II Study;Safety at Phase II Study;Safety at Phase II Study
April 13, 2022, 11:30 p.m.	usa	Immunogenicity at Phase III Study;Immunogenicity at Phase III Study;Immunogenicity at Phase II Study;Immunogenicity at Phase II Study;Safety at Phase III Study;Safety at Phase III Study;Safety at Phase III Study;Safety at Phase II Study;Safety at Phase II Study;Safety at Phase II Study	Immunogenicity at Phase III Study;Immunogenicity at Phase III Study;Immunogenicity at Phase II Study;Immunogenicity at Phase II Study;Safety at Phase III Study;Safety at Phase III Study;Safety at Phase III Study;Safety at Phase II Study;Safety at Phase II Study;Safety at Phase II Study